July 14, 2025 Newswires

BSGM Engages CXG to Acquire FINRA/SEC-Registered Broker-Dealer to Expand Publicly Traded RWA Tokenization Operations

Business Wire

Will Position Streamex as one of the first NASDAQ Listed SEC and FINRA Compliant Issuers of RWA Tokens in the U.S.

LOS ANGELES & VANCOUVER, British Columbia--(BUSINESS WIRE)--
BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig”), which recently merged with Streamex Exchange Corporation (“Streamex”) (together, “BSGM” or the “Company”), is excited to announce a critical step toward becoming one of the first fully regulated Real-World Asset (“RWA”) tokenization companies trading on a major United States exchange: Streamex has engaged Compliance Exchange Group (CXG) to lead and manage the acquisition of a specific FINRA and SEC registered broker-dealer with licensed operations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250714401245/en/

Acquisition of the broker dealer, once complete, will create an entity with a significant first-mover advantage in U.S.-major-exchange-traded RWA-backed tokenized investment opportunities for both major institutional and retail investors in the U.S.
This capability is expected to significantly accelerate adoption and network effect growth of Streamex’s proprietary on-chain RWA commodity market platform.
The Company will also continue to seek out other broker-dealer opportunities in other strategically advantageous countries.

Management notes the near-term vision is to provide access to fully compliant, gold-backed tokenized assets for U.S. institutional and retail investors targeting the $22 trillion global gold market within the $142 trillion commodities sector, while engaging network-effect-based accelerating growth for the Streamex proprietary on-chain RWA-backed commodity exchange and financing ecosystem.

Strategic Benefits After Acquisition

First-Mover Advantage: Streamex will be among the first Nasdaq-listed companies to issue regulated, gold-backed RWA tokens.
Regulatory Compliance: Full compliance with both FINRA and SEC regulations, aligning with emerging U.S. digital asset frameworks.
Scalable Platform: Streamex’s Solana-based blockchain enables fast, low-cost issuance and trading of gold-backed tokens, making gold investment accessible to all, with additional commodities markets to come.
Gold-Backed Growth: Streamex aims to hold significant quantities in vaulted gold by 2026, denominating its balance sheet in physical gold to support a recurring revenue model.

Why It Matters

Near term, the acquisition positions Streamex to bridge traditional finance and blockchain, offering a seamless way to invest in physical gold through digital tokens. Investors can buy fractional shares of gold with the ease of cryptocurrency, while businesses gain new ways to raise capital. This move aligns with global trends, as institutions like BlackRock and Goldman Sachs tokenize billions in assets, and U.S. regulators begin to clarify digital asset rules.

“The acquisition will be a defining moment for Streamex and BioSig,” said Henry McPhie, CEO of BioSig and Co-Founder of Streamex. “Acquiring a regulated broker-dealer will help us build the infrastructure to lead the gold tokenization market in the U.S. Our Nasdaq listing and gold-backed platform will unlock unprecedented opportunities for investors and reshape the $22trillion gold market.”

Morgan Lekstrom, Executive Chairman of the Company, added: “Tokenizing gold is the future of commodity finance. Streamex’s regulated approach and public market presence make it a pioneer in this transformative space, with the potential to redefine how investors access real assets.”

About the Acquisition

The FINRA and SEC-registered broker-dealer, with a presence the U.S., will provide Streamex with the regulatory framework to issue and trade tokenized assets under federal securities laws. Compliance Exchange Group (CXG), a leader in broker-dealer compliance, will oversee the acquisition to ensure seamless integration and adherence to regulations. This acquisition is a critical step toward scaling Streamex’s RWA tokenization platform nationwide.

About Streamex Exchange Corporation

Streamex is a gold treasury and infrastructure company building the foundation for on-chain commodity markets. With a focus on real-world asset (RWA) tokenization, Streamex is developing a vertically integrated platform that combines token issuance, trading infrastructure, and physical gold holdings positioning the Company to become one of Nasdaq's largest public holders of gold bullion.

This strategic approach aligns with Streamex’s mission to reshape global finance by bringing the approximately $142 trillion global commodities market on chain. By merging the security and trust of physical gold with the efficiency and transparency of blockchain, Streamex is creating scalable financial infrastructure for a new era of digital commodities.

The Company plans to hold significant quantities of physical gold, securely vaulted through a top-tier bullion bank. Streamex will denominate the majority of its balance sheet in vaulted gold rather than fiat currency, supporting a long-term, value-based financial model. Combined with Streamex’s Solana-based blockchain infrastructure, this strategy enables a recurring revenue model that supports the issuance of gold-backed digital assets.

Streamex is a wholly owned subsidiary of BioSig Technologies, Inc.

About Compliance Exchange Group (CXG)

CXG specializes in building, managing and supporting Broker-Dealer infrastructure, offering full-service compliance, registration, principal outsourcing, and advisory services.

About BioSig Technologies, Inc.

BioSig Technologies, Inc. is a medical device technology company with an advanced digital signal processing technology platform, the PURE EP™ Platform that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias.

The PURE EP™ Platform enables electrophysiologists to acquire raw signal data in real-time—absent of unnecessary noise or interference—to maximize procedural success and minimize unnecessary inefficiencies. As physician advocates, we believe that the ability to maintain the integrity of intracardiac signals with precision and clarity without driving up procedural costs has never been more pertinent.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential,” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond our control. It is possible that our actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements, depending on factors including whether we will be able to realize the benefits of the acquisition of Streamex, whether shareholder approval of the acquisition will be obtained, and whether we will be able to maintain compliance with Nasdaq’s listing criteria in connection with the acquisition and otherwise. For a discussion of other risks and uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in forward-looking statements, see our filings with the Securities and Exchange Commission, including the section titled “Risk Factors” in our Annual Report on Form 10-K, filed with the SEC on April 15, 2025. We assume no obligation to publicly update or revise our forward-looking statements as a result of new information, future events or otherwise, except as required by law.